Paladin Labs Inc.

Paladin Labs Inc.

March 29, 2006 14:25 ET

Paladin to Present at Upcoming CIBC Biotechnology and Specialty Pharmaceuticals Conference in New York

MONTREAL, QUEBEC--(CCNMatthews - March 29, 2006) - Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, today announced that Jonathan Goodman, President and CEO, will present a corporate update at the CIBC Biotechnology & Specialty Pharmaceuticals Conference on Wednesday, April 5, 2006, at 2:15 p.m. ET, in room 3.04 of the Millennium Broadway Hotel in New York City.

About Paladin Labs

Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian market. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada's leading specialty pharmaceutical companies. Paladin's shares trade on the Toronto Stock Exchange under the symbol PLB. For more information about Paladin, please visit the Company's web site at

This news release may contain forward-looking statements or predictions. These statements represent our judgment as of this date and are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed in such forward-looking statements. Potential risks and uncertainties include, without limitation, those associated with product development, clinical trials, future revenues and profitability, and obtaining marketing approval and other factors that are discussed in the Management Discussion published in the Company's annual reports and Annual Information Form and other filings found on SEDAR at

Contact Information